Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ulipristal acetate dose comparison for medication abortion up to 63 days
ISRCTN40136678Phase 3Recruiting
- Sponsor
- Gynuity Health Projects
- Start
- Oct 2025
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in unintended pregnancy and abortion comparing Ulipristal acetate 60 mg + misoprostol with Ulipristal acetate 30 mg + misoprostol + placebo tablets (2 arms). Primary endpoints: Efficacy and Safety. Started Oct 2025; status: recruiting.
02
Drugs
ulipristalmisoprostol
03
Conditions
unintended pregnancyabortion
Beyond the preview
Go deeper on ISRCTN40136678.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN40136678.